Cat. No. |
Product Name |
Information |
PC-20192 |
ML753286
BCRP inhibitor
|
ML753286 ((S)-ML753286) is a potent, selective BCRP inhibitor with IC50 of 0.6 uM (BCRP efflux transporter), shows no activity against P-glycoprotein (P-gp), organic anion-transporting polypeptide (OATP), or major cytochrome P450s (CYPs). |
PC-43183 |
YHO-13351 free base
ABCG2 inhibitor
|
YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo. |
PC-43182 |
YHO-13351
ABCG2 inhibitor
|
YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo. |
PC-43181 |
YHO-13177
ABCG2 inhibitor
|
YHO-13177 is a acrylonitrile derivative and active form of YHO-13351 that can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo. |
PC-45706 |
KS176
BCRP inhibitor
|
KS176 is a potent and selective inhibitor of BCRP multidrug transporter with IC50 of 0.59 and 1.39 uM in Pheo A and Hoechst 33342 assays, respectively. |
PC-42054 |
Ko143
ABCG2 inhibitor
|
Ko143 is a nontoxic analog of fungal toxin fumitremorgin C and potent, orally bioavailable inhibitor of BCRP (ABCG2) with EC90 of 26 nM. |
PC-42127 |
Brevianamide F
BCRP inhibitor
|
Brevianamide F (Cyclo(L-Pro-L-Trp)) is a naturally occurring 2,5-diketopiperazine that possess interesting breast cancer resistance protein (BCRP) inhibitory activity. |